Multiple molecules and signaling alliances were recently found, such as inhibition of O6-methylguanine-DNA methyltransferase (MGMT) and the bradykinin (BK)-BK B1 receptor axis, which is involved in oncogenesis, malignance, and recurrence of GBM [5,6]. Here, MGMT is linked to glioblastoma.